Mack, M.J., Banning, A.P., et al. (2011) Bypass versus Drug-Eluting Stents at Three Years in Syntax Patients With Diabetes Mellitus or Metabolic Syndrome. The Annals of Thoracic Surgery, 92, 2140-2146.
http://dx.doi.org/10.1016/j.athoracsur.2011.06.028

has been cited by the following article:

• TITLE: Long-Term Survival after CABG in Diabetics with Aggressive Risk Factor Management

  AUTHORS: Kendal Endicott, Conor Hynes, Dominic Emerson, Peter Kokkinos, Michael Greenberg, Gregory Trachiotis

  KEYWORDS: Coronary Artery Bypass Graft, Diabetes, Mortality, Myocardial Infarction

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.4 No.12, December 2, 2014

  ABSTRACT: Objectives: Diabetes is a well-established risk factor for cardiovascular disease, and diabetics have a threefold increase in risk of death from cardiovascular disease compared to non-diabetics. Following coronary artery bypass grafting, tight glycemic control improves short-term outcomes, however limited data exist for long-term outcomes. Here we examine these outcomes in diabetics using aggressive risk factor management. Methods: A retrospective review of all patients under-going coronary artery bypass between 1991 and 2000 at a single Veterans Affairs Medical Center was undertaken. 973 patients were included, 313 with diabetes and 660 without. Strict glucose control was maintained for all patients. Additional risk factor modification, including anti-platelets medications, statins, and beta blockers were also used. Survival analysis was performed. Results: The diabetic group was at higher risk, with age, BSA, and NYHA class all being greater (p